Royal Bank Of Canada Aurinia Pharmaceuticals Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 222,482 shares of AUPH stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

222,482

Previous 56,107 296.53%

Holding current value

$1.79 Million

Previous $411,000 385.89%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$6.75 - $10.44 $1.12 Million - $1.74 Million	166,375 Added 296.53%	222,482 $2 Million
Q3 2024 Nov 14, 2024	BUY	$5.32 - $7.33 $73,506 - $101,278	13,817 Added 32.67%	56,107 $411,000
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $29,615 - $35,587	6,157 Added 17.04%	42,290 $241,000
Q1 2024 Nov 05, 2024	SELL	$4.93 - $9.31 $30,354 - $57,321	-6,157 Reduced 14.56%	36,133 $181,000
Q1 2024 May 15, 2024	SELL	$4.93 - $9.31 $90,376 - $170,670	-18,332 Reduced 33.66%	36,133 $181,000
Q4 2023 Feb 14, 2024	SELL	$7.13 - $9.49 $30,908 - $41,139	-4,335 Reduced 7.37%	54,465 $489,000
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $257,948 - $407,339	33,198 Added 129.67%	58,800 $456,000
Q2 2023 Aug 14, 2023	SELL	$8.96 - $11.69 $164,702 - $214,885	-18,382 Reduced 41.79%	25,602 $247,000
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $73,471 - $139,398	12,369 Added 39.12%	43,984 $482,000
Q4 2022 Feb 14, 2023	SELL	$4.11 - $8.14 $80,671 - $159,771	-19,628 Reduced 38.3%	31,615 $136,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $7,972 - $14,830	1,197 Added 2.39%	51,243 $385,000
Q2 2022 Aug 15, 2022	BUY	$8.95 - $12.8 $158,361 - $226,483	17,694 Added 54.69%	50,046 $503,000
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $55,606 - $124,381	-5,533 Reduced 14.6%	32,352 $401,000
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $299,966 - $558,092	16,871 Added 80.28%	37,885 $867,000
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $1.25 Million - $2.7 Million	-114,804 Reduced 84.53%	21,014 $465,000
Q2 2021 Aug 16, 2021	BUY	$10.0 - $14.52 $1.36 Million - $1.97 Million	135,818 New	135,818 $1.76 Million

Others Institutions Holding AUPH

# of Institutions

227

Shares Held

58.9M

Call Options Held

949K

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Aurinia Pharmaceuticals Inc. Transaction History